BRISBANE, Australia--(BUSINESS WIRE)--IMBcom – The University of Queensland’s (UQ) company for commercialising technology from the Institute for Molecular Bioscience (IMB) - today announced that PROLOR Biotech Inc (formerly Modigene Inc) has taken out a non-exclusive licence to UQ’s human growth hormone receptor cell line.
